March 26

I decided not to take any action today and will resume checking my stocks on Monday over break. My overall portfolio value dropped from yesterday, possibly due to the fact that both of my pharmaceutical stocks went down today. My biggest gainer, Biomarin Pharmaceuticals, went down quite a bit today, but it had also gained significantly the past few days. Hess Corporation took a hit, but Accenture sort of evened out the loss. Overall, the change wasn't too significant, so the market itself may not have changed much either.